Synopsis
Synopsis
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bentelan
2. Betamethason Sodium Phosphate
3. Betamethasone 21-phosphate
4. Betamethasone Disodium Phosphate
5. Betamethasone Disodium Phosphate, (11beta)-isomer
6. Betamethasone Phosphate
7. Betamethasone Sodium Phosphate, (11beta,16beta)-isomer
8. Betnesol
9. Celestone Phosphate
10. Rinderone
1. 151-73-5
2. Bentelan
3. Betamethasone 21-phosphate Disodium Salt
4. Betamethasone 21-phosphate Disodium
5. Betamethasone Disodium Phosphate
6. Betamethazone Disodium Phosphate
7. Betamethasone 21-disodium Phosphate
8. Beta-methasone Sodium Phosphate
9. Betamethasone 21-phosphate Sodium Salt
10. 7bk02scl3w
11. Chebi:3078
12. 9-fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-(disodium Phosphate)
13. Betamethasone Sodium Phosphate, Usp
14. Disodium Betamethasone 21-phosphate
15. Beta-methasone Phosphate
16. Celestone Phosphate Injection
17. Nsc 90616
18. Disodium;[2-[(8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Phosphate
19. Sodium 2-((8s,9r,10s,11s,13s,14s,16s,17r)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3h-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl Phosphate
20. Nsc-90616
21. Beta-methasone, Disodium Phosphate
22. Einecs 205-797-0
23. Unii-7bk02scl3w
24. Beta-methasone Disodium Phosphate
25. Mfcd00200361
26. Betamethasone Sodium Phosphate [usp:jan]
27. Betamethasonesodiumphosphate
28. Schembl8418
29. Dsstox_cid_27137
30. Dsstox_rid_82144
31. Dsstox_gsid_47137
32. Chembl1200762
33. Dtxsid8047137
34. Tox21_302467
35. Akos015896371
36. Ac-2162
37. Ncgc00256717-01
38. As-62442
39. Cas-151-73-5
40. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Disodium Salt, (11.beta.,16.beta.)-
41. Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17-dihydroxy-16-methyl-21-(phosphonooxy)-, Disodium Salt, (11beta,16beta)-
42. Pregna-1,4-diene-3,20-dione, 9-fluoro-11-beta,17,21-trihydroxy-16-beta-methyl-, 21-(dihydrogen Phosphate), Disodium Salt
43. Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16beta-methyl-, 21-(dihydrogen Phosphate), Disodium Salt
44. Betamethasone Sodium Phosphate (jp17/usp)
45. Betamethasone Sodium Phosphate [jan]
46. B4110
47. Betamethasone 21-phosphate Disodium, >=97%
48. Betamethasone Sodium Phosphate [mart.]
49. Betamethasone Sodium Phosphate [vandf]
50. Betamethasone Sodium Phosphate [usp-rs]
51. Betamethasone Sodium Phosphate [who-dd]
52. D00972
53. Betamethasone Sodium Phosphate [green Book]
54. Betamethasone Sodium Phosphate [ep Impurity]
55. Betamethasone Sodium Phosphate [ep Monograph]
56. Betamethasone Sodium Phosphate [orange Book]
57. J-008838
58. Betamethasone Sodium Phosphate [usp Monograph]
59. Q27105936
60. Betamethasone Sodium Phosphate Component Of Celestone Soluspan
61. Celestone Soluspan Component Betamethasone Sodium Phosphate
62. Betamethasone Sodium Phosphate, European Pharmacopoeia (ep) Reference Standard
63. Betamethasone Sodium Phosphate, United States Pharmacopeia (usp) Reference Standard
64. 9-fluoro-11.beta.,17,21-trihydroxy-16.beta.-methylpregna-1,4-diene-3,20-dione 21-(disodium Phosphate)
65. Disodium 9-fluoro-11beta,17-dihydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-21-yl Phosphate
| Molecular Weight | 516.4 g/mol |
|---|---|
| Molecular Formula | C22H28FNa2O8P |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 516.13012157 g/mol |
| Monoisotopic Mass | 516.13012157 g/mol |
| Topological Polar Surface Area | 147 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 962 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Glucocorticoids
A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
Regulatory Info : DISCN
Registration Country : USA
BETAMETHASONE SODIUM PHOSPHATE
Brand Name : BETAMETHASONE SODIUM PHOSPHATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 3MG BASE/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 85738
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Betnovate
Dosage Form : Cream
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Betnovate Scalp Appl
Dosage Form : Liq
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Celestone Injection
Dosage Form : INJ
Dosage Strength : 4mg/ml
Packaging : 1X5mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Celestone Soluspan Injection 1ml
Dosage Form : INJ
Dosage Strength : 3mg/ml
Packaging : 100X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Brand Name : CELESTONE SOLUSPAN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 3MG/ML;EQ 3MG BASE/ML
Packaging :
Approval Date : 1982-01-01
Application Number : 14602
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Switzerland
Brand Name : Diprosone
Dosage Form : Cream
Dosage Strength : 0.05%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Turkey
Betamethasone Sodium Phosphate
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Betamethasone Sodium Phosphate
Brand Name :
Dosage Form : Tablet IP
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Italy
Betamethasone Sodium Phosphate; Tetracycline Hydrochloride
Brand Name : Betafloroto
Dosage Form :
Dosage Strength : Gtt Orl Bottle + Bottle B 3 Ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code :
BETAMETHASONE SODIUM PHOSPHATE
Brand Name : BETAMETHASONE SODIUM PHOSPHATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 3MG BASE/ML
Approval Date : 1982-01-01
Application Number : 85738
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AB
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Brand Name : BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 3MG/ML;EQ 3MG BASE/ML
Approval Date : 2009-07-31
Application Number : 90747
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code :
BETAMETHASONE SODIUM PHOSPHATE
Brand Name : CELESTONE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : EQ 3MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Approval Date : 1982-01-01
Application Number : 17561
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :
RLD : No
TE Code : AB
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Brand Name : BETAMETHASONE ACETATE AND BETAMETHASONE SODIUM PHOSPHATE
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 3MG/ML;EQ 3MG BASE/ML
Approval Date : 2023-01-17
Application Number : 77838
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code : AB
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE
Brand Name : CELESTONE SOLUSPAN
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 3MG/ML;EQ 3MG BASE/ML
Approval Date : 1982-01-01
Application Number : 14602
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]South Africa
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Dossiers
Regulatory Info :
Registration Country : India
Betamethasone Sodium Phosphate
Brand Name :
Dosage Form : Injection
Dosage Strength : 4mg/1ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Betamethasone Sodium Phosphate
Dosage : Injection
Dosage Strength : 4mg/1ml
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Betamethasone Sodium Phosphate
Brand Name :
Dosage Form : Ampoule
Dosage Strength : 4MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging :
Regulatory Info :
Betamethasone Sodium Phosphate
Dosage : Ampoule
Dosage Strength : 4MG/ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey
Regulatory Info :
Registration Country : India
Betamethasone Sodium Phosphate
Brand Name :
Dosage Form : Tablet IP
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Betamethasone Sodium Phosphate
Dosage : Tablet IP
Dosage Strength : 0.5MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : Turkey
Betamethasone Sodium Phosphate; Betamethasone Dipropionate
Brand Name : SERTOSPAN
Dosage Form : SUSPENSION FOR INJECTI...
Dosage Strength : 2MG; 5MG
Packaging : 1 OR 5 AMPULES
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Packaging : 1 OR 5 AMPULES
Regulatory Info :
Betamethasone Sodium Phosphate; Betamethasone Dipropionate
Dosage : SUSPENSION FOR INJECTI...
Dosage Strength : 2MG; 5MG
Brand Name : SERTOSPAN
Approval Date :
Application Number :
Registration Country : Turkey
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Solubilizers
Parenteral
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
97
PharmaCompass offers a list of Betamethasone Sodium Phosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Betamethasone Sodium Phosphate manufacturer or Betamethasone Sodium Phosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Betamethasone Sodium Phosphate manufacturer or Betamethasone Sodium Phosphate supplier.
PharmaCompass also assists you with knowing the Betamethasone Sodium Phosphate API Price utilized in the formulation of products. Betamethasone Sodium Phosphate API Price is not always fixed or binding as the Betamethasone Sodium Phosphate Price is obtained through a variety of data sources. The Betamethasone Sodium Phosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Rinderone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rinderone, including repackagers and relabelers. The FDA regulates Rinderone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rinderone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rinderone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rinderone supplier is an individual or a company that provides Rinderone active pharmaceutical ingredient (API) or Rinderone finished formulations upon request. The Rinderone suppliers may include Rinderone API manufacturers, exporters, distributors and traders.
click here to find a list of Rinderone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rinderone DMF (Drug Master File) is a document detailing the whole manufacturing process of Rinderone active pharmaceutical ingredient (API) in detail. Different forms of Rinderone DMFs exist exist since differing nations have different regulations, such as Rinderone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rinderone DMF submitted to regulatory agencies in the US is known as a USDMF. Rinderone USDMF includes data on Rinderone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rinderone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rinderone suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rinderone Drug Master File in Japan (Rinderone JDMF) empowers Rinderone API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rinderone JDMF during the approval evaluation for pharmaceutical products. At the time of Rinderone JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rinderone suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Rinderone Drug Master File in Korea (Rinderone KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Rinderone. The MFDS reviews the Rinderone KDMF as part of the drug registration process and uses the information provided in the Rinderone KDMF to evaluate the safety and efficacy of the drug.
After submitting a Rinderone KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Rinderone API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Rinderone suppliers with KDMF on PharmaCompass.
A Rinderone CEP of the European Pharmacopoeia monograph is often referred to as a Rinderone Certificate of Suitability (COS). The purpose of a Rinderone CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Rinderone EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Rinderone to their clients by showing that a Rinderone CEP has been issued for it. The manufacturer submits a Rinderone CEP (COS) as part of the market authorization procedure, and it takes on the role of a Rinderone CEP holder for the record. Additionally, the data presented in the Rinderone CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Rinderone DMF.
A Rinderone CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Rinderone CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Rinderone suppliers with CEP (COS) on PharmaCompass.
A Rinderone written confirmation (Rinderone WC) is an official document issued by a regulatory agency to a Rinderone manufacturer, verifying that the manufacturing facility of a Rinderone active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Rinderone APIs or Rinderone finished pharmaceutical products to another nation, regulatory agencies frequently require a Rinderone WC (written confirmation) as part of the regulatory process.
click here to find a list of Rinderone suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rinderone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rinderone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rinderone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rinderone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rinderone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rinderone suppliers with NDC on PharmaCompass.
Rinderone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rinderone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rinderone GMP manufacturer or Rinderone GMP API supplier for your needs.
A Rinderone CoA (Certificate of Analysis) is a formal document that attests to Rinderone's compliance with Rinderone specifications and serves as a tool for batch-level quality control.
Rinderone CoA mostly includes findings from lab analyses of a specific batch. For each Rinderone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rinderone may be tested according to a variety of international standards, such as European Pharmacopoeia (Rinderone EP), Rinderone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rinderone USP).
